Calprotectin ELISA
The BÜHLMANN fCAL® ELISA (EK-CAL) is the UK market-leading calprotectin ELISA. It provides quantitative in vitro determination of fecal calprotectin in high sample throughput environments.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
The BÜHLMANN fCAL® ELISA (EK-CAL) is the UK market-leading calprotectin ELISA. It provides quantitative in vitro determination of fecal calprotectin in high sample throughput environments.
The kit format is a microtitre plate based assay that can be performed manually or on an automated ELISA system to reduce hands-on time.
CE marked protocols are available for the Dynex DS2 and DSx plus the Grifols Triturus®. Alpha Laboratories Ltd. supplies the Dynex DS2 for capital purchase or reagent rental.
Two different protocols are available with the fCAL ELISA to cover the ranges required for IBD and IBS differentiation plus the extended range format for use in monitoring patient therapy and mucosal healing. This reduces the need for further dilution and repeated assay.
Features:
- Ranges are 10-600µg/g or 30-1800µg/g
- A consistent cut-off of 50µg/g is used throughout the Bühlmann Calprotectin range
- Simple extraction procedures for Calprotectin are available using the dedicated CALEX® Cap device or the Schebo or Roche extraction devices
All reagents, standards, and controls are provided in one kit and are ready for use.
There is no requirement for reconstituting any component, apart from the wash buffer.
This minimizes any errors as well as ensuring a long shelf life.
Brochures
Diagnostics for Digestive Health Management
This product brochure presents BÜHLMANN Laboratories products used for calprotectin testing fecal matter. The brochure provides technical information about the products and also information about their application.
Join the CALEX revolution
In this product brochure, Alpha Laboratories describes how the BÜHLMANN CALEX® provides rapid, clean and consistent sample preparation every time.
Fecal calprotectin in patients with suspected colorectal cancer: A diagnostic accuracy study
In this article, Alpha Laboratories describes a study that was undertaken to determine the diagnostic accuracy of fecal calprotectin in patients referred with suspected colorectal cancer, both for clinically significant colorectal neoplasia and for all organic enteric disease.
Grifols and Inpeco join forces to deliver transfusion medicine ‘lab of the future’
The broader diagnostic capabilities enhance Grifols leadership in developing and providing a complete set of automation solutions that optimize operations regardless of size, from small labs to large blood banks
